Why Australian Pharmaceutical Industries Ltd (ASX:API) shares have been smashed today

The Australian Pharmaceutical Industries Ltd (ASX:API) share price has been smashed today. Here's why…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the worst performers on the market today has been the Australian Pharmaceutical Industries Ltd (ASX: API) share price.

In late morning trade the pharmacy chain operator and wholesaler's shares are down 8.5% to $1.73.

At one stage the shares of the company behind the Priceline pharmacy chain were as much as 10% lower at $1.70.

Why are Australian Pharmaceutical Industries' shares sinking lower?

With no news out of the company, it appears as though a broker note out of Credit Suisse this morning has been the catalyst for the selloff.

According to the note, the broker has downgraded Australian Pharmaceutical Industries' shares to an underperform rating from neutral and cut the price target on them from $1.63 to $1.55.

This price target implies further downside of almost 10.5% over the next 12 months for the company's shares.

Credit Suisse fears that the impressive share price rise since its Clearskincare acquisition in August means its shares are now in danger of a sharp pullback when its releases its results in October.

The company's shares recently hit a 52-week high of $1.94 on the back of its expansion into the skincare market.

Management's belief that the acquisition is highly compelling, complementary, and will lead to a more diversified business with accelerated growth potential appears to have gone down well with investors.

However, Credit Suisse doesn't think investors should get too excited just yet. Especially with the company's core business operating in a challenging environment with both PBS and retail revenues coming under pressure.

The broker believes that its shares could be de-rated next month when the full extent of the tough trading conditions are revealed.

Should you buy the dip?

While I do like that management is diversifying its business, for now I completely agree with Credit Suisse on Australian Pharmaceutical Industries and think investors would be better off staying clear of its shares until after its full year results release.

In addition to this, I think industry peer Sigma Healthcare Ltd (ASX: SIG) would be best avoided. As well as suffering from tough trading conditions, Sigma has just lost one of its biggest supply contracts. I think this earnings gap will be hard to fill.

Instead of these shares, I would consider up and coming healthcare sector peers Paragon Care Ltd (ASX: PGC) and Volpara Health Technologies Ltd (ASX: VHT).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why APA, Flight Centre, Reece, and Transurban shares are falling today

These shares are having a tough finish to the week. But why?

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Share Fallers

Why Bannerman Energy, Life360, Strike Energy, and Xero shares are tumbling today

These shares are under pressure on Thursday. But why?

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Share Fallers

Why DroneShield, Neuren, Paradigm, and Pilbara Minerals shares are roaring higher today

These shares are having a strong session on Thursday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Betr, Develop Global, Northern Star, and Paragon Care shares are dropping today

These shares are having a tough time on hump day. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why APA, DroneShield, EOS, and Woodside shares are tumbling today

These shares are missing out on the good times on Tuesday.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Adairs, ANZ, Aurelia Metals, and Pilbara Minerals shares are falling today

These shares are having a tough start to the week in the red. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why ANZ, Clarity, IGO, and Pilbara Minerals shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Aurelia Metals, Centuria Office, Meeka Metals, and Resolute shares are tumbling today

These shares are having a tough time on Thursday. Let's find out why.

Read more »